219 related articles for article (PubMed ID: 30506129)
21. Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan.
Kee KM; Lu SN
Oncology; 2011; 81 Suppl 1():36-40. PubMed ID: 22212934
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma.
Desjardins LA
Clin J Oncol Nurs; 2002; 6(2):107-8. PubMed ID: 11889672
[TBL] [Abstract][Full Text] [Related]
23. An Exploration of Patient Navigation and Community Health Worker Activities Across National Comprehensive Cancer Control Programs.
Rohan EA; McDougall R; Townsend JS
Health Equity; 2018; 2(1):366-374. PubMed ID: 30569028
[No Abstract] [Full Text] [Related]
24. Beasley's 1981 paper: The power of a well-designed cohort study to drive liver cancer research and prevention.
Koshiol J; Liu Z; O'Brien TR; Hildesheim A
Cancer Epidemiol; 2018 Apr; 53():195-199. PubMed ID: 29396075
[TBL] [Abstract][Full Text] [Related]
25. Prevention of liver cancer.
Guyton KZ; Kensler TW
Curr Opin Oncol; 1997 Sep; 9(5):492-6. PubMed ID: 9327229
[TBL] [Abstract][Full Text] [Related]
26. Cancer prevention by vaccination against hepatitis B.
Chang MH
Recent Results Cancer Res; 2009; 181():85-94. PubMed ID: 19213561
[TBL] [Abstract][Full Text] [Related]
27. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
28. Risk factors and prevention of hepatocellular carcinoma in HCV infection.
Benvegnù L; Alberti A
Dig Dis Sci; 1996 Dec; 41(12 Suppl):49S-55S. PubMed ID: 9011476
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology, risk factors, and natural history of hepatocellular carcinoma.
Montalto G; Cervello M; Giannitrapani L; Dantona F; Terranova A; Castagnetta LA
Ann N Y Acad Sci; 2002 Jun; 963():13-20. PubMed ID: 12095924
[TBL] [Abstract][Full Text] [Related]
30. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.
Mazzella G; Accogli E; Sottili S; Festi D; Orsini M; Salzetta A; Novelli V; Cipolla A; Fabbri C; Pezzoli A; Roda E
J Hepatol; 1996 Feb; 24(2):141-7. PubMed ID: 8907566
[TBL] [Abstract][Full Text] [Related]
31. Prevention of Liver Cancer Through the Early Detection of Risk-related Behavior Among Hepatitis B or C Carriers.
Fan JY; Huang TJ; Jane SW; Chen MY
Cancer Nurs; 2015; 38(3):169-76. PubMed ID: 24836958
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
Kao JH
Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
[TBL] [Abstract][Full Text] [Related]
33. Viral hepatitis and hepatocellular carcinoma.
Sallie R; Di Bisceglie AM
Gastroenterol Clin North Am; 1994 Sep; 23(3):567-79. PubMed ID: 7989095
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma.
Fiorino S; Bacchi-Reggiani ML; Visani M; Acquaviva G; Fornelli A; Masetti M; Tura A; Grizzi F; Zanello M; Mastrangelo L; Lombardi R; Di Tommaso L; Bondi A; Sabbatani S; Domanico A; Fabbri C; Leandri P; Pession A; Jovine E; de Biase D
World J Gastroenterol; 2016 Apr; 22(15):3907-36. PubMed ID: 27099435
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis.
Lehman EM; Wilson ML
Int J Cancer; 2009 Feb; 124(3):690-7. PubMed ID: 18973270
[TBL] [Abstract][Full Text] [Related]
36. Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease.
Younossi Z; Kochems K; de Ridder M; Curran D; Bunge EM; de Moerlooze L
Hum Vaccin Immunother; 2017 Nov; 13(11):2695-2706. PubMed ID: 28742983
[TBL] [Abstract][Full Text] [Related]
37. Improving the identification of priority populations to increase hepatitis B testing rates, 2012.
van Gemert C; Wang J; Simmons J; Cowie B; Boyle D; Stoove M; Enright C; Hellard M
BMC Public Health; 2016 Feb; 16():95. PubMed ID: 26832144
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma in HIV positive patients.
Nunnari G; Berretta M; Pinzone MR; Di Rosa M; Berretta S; Cunsolo G; Malaguarnera M; Cosentino S; De Paoli P; Schnell JM; Cacopardo B
Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1257-70. PubMed ID: 23047511
[TBL] [Abstract][Full Text] [Related]
39. Late hepatitis B and C diagnosis in relation to disease decompensation and hepatocellular carcinoma development.
Samji H; Yu A; Kuo M; Alavi M; Woods R; Alvarez M; Dore GJ; Tyndall M; Krajden M; Janjua NZ;
J Hepatol; 2017 Nov; 67(5):909-917. PubMed ID: 28684103
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of hepatitis B surface antigen and HCV antibodies in hepatocellular carcinoma cases in Karachi, Pakistan.
Abdul Mujeeb S; Jamal Q; Khanani R; Iqbal N; Kaher S
Trop Doct; 1997 Jan; 27(1):45-6. PubMed ID: 9030022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
